CPIX · Cumberland Pharmaceuticals Inc
United States · RS rating 92 · As of 2026-10-14
| Price | 7.49 USD |
|---|---|
| 1-day change | +4.5% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 95 / 54 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 51 / 52 / 62 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | +30.8% |
| Sales growth Q/Q | +65.0% |
| Distance from 52-week high | +16.5% |
| Market cap (USD) | $58.3M |